About: Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits
Creator	Nagasawa, Masayuki Kurosaki, Masayuki Furuya, Maki Izumi, Namiki Nagata, Kaoru Suzaki, Shinichiro Takahashi, Yui Taki, Reiko Yamaguchi, Yoshimi
source	Medline; PMC
abstract	We examined anti-SARS-CoV-2 IgG and IgM antibodies in 45 serum samples from 26 patients with COVID-19, who were admitted in our hospital by using three different ELISA kits. All patients had pneumonia at admission, and 7 patients required mechanical ventilator support and grouped in severe case. Anti-SARS-CoV-2 IgG and IgM antibodies turned to be partially positive between the 6th and 10th days, more than 84% positive between the 11th and 15th days, and 100% after the 16th day. One ELISA kit revealed poorer sensitivity for anti-SARS-CoV-2 IgM antibody. Negative conversion of IgM antibody was not observed in the 30th day in our cohort. All three ELISA kits showed no false positive reaction for negative serum samples. Between severe and moderate cases, there was no significant difference in the trends of anti-SARS-CoV-2 IgG and IgM antibody.
has issue date	2020-07-23(xsd:dateTime)
bibo:doi	10.1007/s42399-020-00409-7
bibo:pmid	32838175
has license	no-cc
sha1sum (hex)	72494e86dd6b2589eb7055a0296bd2a015d4df65
schema:url	https://doi.org/10.1007/s42399-020-00409-7
resource representing a document's title	Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits
has PubMed Central identifier	PMC7377663
has PubMed identifier	32838175
schema:publication	SN Compr Clin Med
resource representing a document's body	covid:72494e86dd6b2589eb7055a0296bd2a015d4df65#body_text
is schema:about of	named entity 'days' named entity 'antibody' named entity 'cases' named entity 'COVID-19' named entity 'Antibodies' covid:arg/72494e86dd6b2589eb7055a0296bd2a015d4df65 named entity 'negative' named entity 'day' named entity 'COVID-19' named entity 'revealed' named entity 'IgG' named entity 'false positive' named entity 'SARS-CoV-2' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'IgG' named entity 'IgM antibodies' named entity 'IgG' named entity 'RT-PCR test' named entity 'RT-PCR' named entity 'epidemiological study' named entity 'immunological responses' named entity 'chest CT' named entity 'antibody' named entity 'Statistical analysis' named entity 'emerging infectious disease' named entity 'RT-PCR test' named entity 'epidemiological analysis' named entity 'antibody' named entity 'SARS-CoV-2' named entity 'Rapid Test' named entity 'public health' named entity 'acute phase' named entity 'COVID-19' named entity 'ELISA test' named entity 'SARS-CoV-2' named entity 'multiple organ failure' named entity 'Tokyo, Japan' named entity 'IgG' named entity 'coronavirus' named entity 'COVID' named entity 'infection' named entity 'COVID' named entity 'China' named entity 'Tokyo' named entity 'COVID' named entity 'RT-PCR test' named entity 'diagnostic tool' named entity 'serum samples' named entity 'acute infection' named entity 'negative control' named entity 'unanimous decision' named entity 'significant difference' named entity 'informed consent' named entity 'SARS-CoV-2' named entity 'mechanical ventilator' named entity 'Rapid Test' named entity 'epidemiological analysis' named entity 'IgG' named entity 'pneumonia' named entity 'IgM' named entity 'antibody test' named entity 'SARS-CoV-2' named entity 'antibody' named entity 'Japan' named entity 'SARS-CoV-2' named entity 'virus' named entity 'infection' named entity 'June 2020' named entity 'Biotech' named entity 'Rapid Test' named entity 'serum samples' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software